Another Press Release:
another awkward google translation, but you get the idea!
New info, University of Geneva is involved
THE FOUNDATION HILARESCERE
THE PURPOSE OF PROMOTING THE ACTIVITIES OF MEDICAL AND SCIENTIFIC RESEARCH IN THE FIELD OF DISEASES OF UNKNOWN ORIGIN.
BUSINESS 'SEARCH FOR THE TREATMENT OF MS: CCSVI, CARE AND DISCOVERY OF A NEW VASCULAR DISEASE THAT IS THE ASSOCIATED WITH MULTIPLE SCLEROSIS
The Foundation Hilarescere was born as a tool to exploit, by providing resources and links to a search for appropriate medical and scientific insights addressed to fully understand and cure diseases that are partly unknown.
As has happened in this first study, which was developed as interdisciplinary research between scholars.
The Foundation HILARESCERE, of which Professor Fabio Roversi-Monaco is the president, was born at the initiative of the Fondazione Cassa di Risparmio in Bologna.
The first study involved a research team consisting of the Italian group led by Professor vascular Paolo Zamboni, University of Ferrara and the group of neurological neurosciences at the Bellaria Bologna led by Dr Fabrizio Salvi.
Their research aims to investigate the mechanisms of activation of a disease whose etiopathogenesis is still unknown: multiple sclerosis. This has helped to have the tools to identify the precise contours science because of the cerebro-spinal venous (CCSVI) to generate an international collaboration with Marc Jacobs Institute of the University of New York and has funded a number of international publications.
Hilarescere The Foundation has created the conditions for doing science is that to ensure that the scientific national and international will to confront the pending discovered to have a definitive confirmation that the results of these first years of research are assumed.
CCSVI: research in progress
Are ongoing studies to further investigate the relationship between MS and CCSVI, through international collaboration between the Italian research team and the University of the State of New York, Jacobs Institute of Neurology in Buffalo, and the University of Geneva. Since 2006, the Italian group also carries out trials of treatment of CCSVI presented in London last April all'Imperial College. This further research is to determine whether new techniques for early diagnosis and treatment of CCSVI can also bring benefit to multiple sclerosis associated with it.
In Bologna Tuesday September 8, during Venous Function And Multiple Sclerosis, an international forum, it will allow the comparison on all subjects of the research carried out by the team of Prof. Zamboni, and complete presentation of the work done.
Intervene in the proceedings, among others, all scholars worldwide who have produced substantial data that validates or are associated to the data originally described by the Italian group.
The Foundation Hilarescere, as stated in the constitution, aims to promote the activities of medical and scientific research in the field of disease etiopathogenesis unknown or poorly defined, with standard diagnostic and therapeutic low impact on the quality of life of people are affected, especially in the area of chronic and degenerative diseases of the nervous system and of the vascular, with particular reference to multiple sclerosis. It must also promote and support the dissemination of techniques for prevention, diagnosis, treatment and care to those affected by these diseases.
The intrinsic value related to the care and support for the sick of the territory, in the case of illness still unknown, is one of the factors that have particular reasons for the Casa di Risparmio in Bologna, which has acknowledged the reality of its territory and the formation proceed in an increasingly scientific in this field.
The creation and support for Hilarescere Foundation, is the instrument that made possible the realization, with the right means, of what was already a reality and its scientific credibility, while still in the embryonic stage partly because scientific intuition.
Hilarescere, from Latin, to hilarious, happy.